Skip to main content

Ventricular Arrythmia

0
Pipeline Programs
6
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
2 programs
Fixed TiltN/A1 trial
Temporary implantation of defibrillation coils and pulse generatorN/A1 trial
Active Trials
NCT03632057Completed779Est. Apr 2025
NCT04809701Completed30Est. Mar 2022
MicroPort
MicroPortChina - Shanghai
2 programs
INVICTA leadN/A1 trial
Implant of the INVICTA leadN/A1 trial
Active Trials
NCT04590144Completed446Est. Dec 2024
NCT03766919Unknown33Est. Mar 2021
AtaCor Medical
AtaCor MedicalCA - San Clemente
1 program
Atala™ leadN/A1 trial
Active Trials
NCT06592001Active Not Recruiting19Est. Dec 2028
Precision BioSciences
1 program
VIVON/A
Catheter Precision
Catheter PrecisionSC - Fort Mill
1 program
VIVON/A1 trial
Active Trials
NCT04990089Completed125Est. Sep 2024
Boston Scientific
Boston ScientificCA - Valencia
1 program
ommitence of defibrillation testingN/A1 trial
Active Trials
NCT03495297Active Not Recruiting965Est. Jul 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
AtaCor MedicalAtala™ lead
Catheter PrecisionVIVO
MicroPortINVICTA lead
AbbottTemporary implantation of defibrillation coils and pulse generator
MicroPortImplant of the INVICTA lead
AbbottFixed Tilt
Boston Scientificommitence of defibrillation testing

Clinical Trials (7)

Total enrollment: 2,397 patients across 7 trials

NCT06592001AtaCor MedicalAtala™ lead

Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study

Start: Feb 2025Est. completion: Dec 202819 patients
N/AActive Not Recruiting
NCT04990089Catheter PrecisionVIVO

VIVO European Observational Registry

Start: Oct 2021Est. completion: Sep 2024125 patients
N/ACompleted
NCT04590144MicroPortINVICTA lead

Safety and Performance of INVICTA Ventricular DF4 LEADS With Active Fixation-(APOLLO)

Start: Jun 2021Est. completion: Dec 2024446 patients
N/ACompleted
NCT04809701AbbottTemporary implantation of defibrillation coils and pulse generator

Non-vascular ICD Electrode Configuration Feasibility Study

Start: Mar 2021Est. completion: Mar 202230 patients
N/ACompleted
NCT03766919MicroPortImplant of the INVICTA lead

Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped With DF4 Connector

Start: Dec 2018Est. completion: Mar 202133 patients
N/AUnknown
NCT03632057AbbottFixed Tilt

Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Implantable-Cardioverter Population

Start: Jun 2018Est. completion: Apr 2025779 patients
N/ACompleted
NCT03495297Boston Scientificommitence of defibrillation testing

A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing

Start: May 2018Est. completion: Jul 2025965 patients
N/AActive Not Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.